BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31914333)

  • 1. Novel immunotherapy combinations for genitourinary cancers.
    Al Harthy M; Redman J; Madan RA
    Expert Opin Biol Ther; 2020 Mar; 20(3):253-262. PubMed ID: 31914333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
    Ă–zdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
    Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Landscape of Immunotherapy in Genitourinary Malignancies.
    Alhalabi O; Rafei H; Bilen MA; Shah AY
    Adv Exp Med Biol; 2020; 1244():107-147. PubMed ID: 32301013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.
    Surolia I; Gulley J; Madan RA
    Expert Opin Biol Ther; 2014 Dec; 14(12):1769-81. PubMed ID: 25212872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunotherapy revolution in genitourinary malignancies.
    U Gandhy S; Madan RA; Aragon-Ching JB
    Immunotherapy; 2020 Aug; 12(11):819-831. PubMed ID: 32594815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy in genitourinary malignancies.
    Wattenberg MM; Fong L; Madan RA; Gulley JL
    Curr Opin Urol; 2016 Nov; 26(6):501-7. PubMed ID: 27471994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination immunotherapy in genitourinary malignancies.
    Hoffman-Censits J; Wilde L
    Curr Opin Urol; 2016 Nov; 26(6):523-8. PubMed ID: 27517637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology and immunotherapy in genitourinary malignancies.
    Tsiatas M; Grivas P
    Ann Transl Med; 2016 Jul; 4(14):270. PubMed ID: 27563657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel immunotherapies in GU malignancies.
    Drakaki A; McDermott DF
    Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy advances in uro-genital malignancies.
    Ratta R; Zappasodi R; Raggi D; Grassi P; Verzoni E; Necchi A; Di Nicola M; Salvioni R; de Braud F; Procopio G
    Crit Rev Oncol Hematol; 2016 Sep; 105():52-64. PubMed ID: 27372200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising immunotherapy for prostate cancer.
    Henegan JC; Sonpavde G
    Expert Opin Biol Ther; 2018 Feb; 18(2):109-120. PubMed ID: 29231062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies.
    Solanki AA; Bossi A; Efstathiou JA; Lock D; Mondini M; Ramapriyan R; Welsh J; Kang J
    Eur Urol Oncol; 2019 Feb; 2(1):79-87. PubMed ID: 30929848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining immunotherapies for the treatment of prostate cancer.
    Redman JM; Gulley JL; Madan RA
    Urol Oncol; 2017 Dec; 35(12):694-700. PubMed ID: 29146441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
    Bigot F; Bonnet C; Massard C
    Bull Cancer; 2017 Apr; 104(4):370-379. PubMed ID: 28237355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy: new applications in urologic oncology.
    Hurwitz ME; Sokhn J; Petrylak DP
    Curr Opin Urol; 2016 Nov; 26(6):535-42. PubMed ID: 27584025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in immunotherapy for the treatment of prostate cancer.
    Sonpavde G; Agarwal N; Choueiri TK; Kantoff PW
    Expert Opin Biol Ther; 2011 Aug; 11(8):997-1009. PubMed ID: 21675925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy in uropathology].
    Verkarre V; Roussel H; Granier C; Tartour E; Allory Y
    Ann Pathol; 2017 Feb; 37(1):90-100. PubMed ID: 28111042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in immunotherapy for kidney cancer.
    Ball MW; Allaf ME; Drake CG
    Discov Med; 2016 Apr; 21(116):305-13. PubMed ID: 27232516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint inhibitors in genitourinary malignancies.
    Thana M; Wood L
    Curr Oncol; 2020 Apr; 27(Suppl 2):S69-S77. PubMed ID: 32368176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of Emerging Immunotargets of Genitourinary Tumors.
    Montironi R; Santoni M; Cheng L; Lopez-Beltran A; Massari F; Matrana MR; Moch H; Scarpelli M
    Curr Drug Targets; 2016; 17(7):750-6. PubMed ID: 26648079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.